These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12079211)
1. Dendritic cell vaccination for the treatment of skin cancer. Nestle FO Recent Results Cancer Res; 2002; 160():165-9. PubMed ID: 12079211 [TBL] [Abstract][Full Text] [Related]
2. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. da Cunha A; Antoniazi Michelin M; Cândido Murta EF Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825 [TBL] [Abstract][Full Text] [Related]
3. Dendritic cell vaccination as a treatment modality for melanoma. Eubel J; Enk AH Expert Rev Anticancer Ther; 2009 Nov; 9(11):1631-42. PubMed ID: 19895246 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells for specific cancer immunotherapy. Meidenbauer N; Andreesen R; Mackensen A Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216 [TBL] [Abstract][Full Text] [Related]
5. Advances in dendritic cell-based vaccine of cancer. Zhang X; Gordon JR; Xiang J Cancer Biother Radiopharm; 2002 Dec; 17(6):601-19. PubMed ID: 12537664 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cells and cutaneous T-cell lymphomas. Ni X; Duvic M G Ital Dermatol Venereol; 2011 Apr; 146(2):103-13. PubMed ID: 21505396 [TBL] [Abstract][Full Text] [Related]
8. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients. Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and their role in cancer immunotherapy. Jalili A Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012 [TBL] [Abstract][Full Text] [Related]
10. Optimizing dendritic cell-based immunotherapy for cancer. Zhong H; Shurin MR; Han B Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749 [TBL] [Abstract][Full Text] [Related]
19. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma. Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076 [TBL] [Abstract][Full Text] [Related]
20. The impact of dendritic cell-tumor fusion cells on cancer vaccines - past progress and future strategies. Kajihara M; Takakura K; Ohkusa T; Koido S Immunotherapy; 2015; 7(10):1111-22. PubMed ID: 26507578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]